Walgreens Boots Alliance Inc
WBA: XNAS (USA)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
$95.00 | Knlfl | Wpbp |
Walgreens Increases Full-Year Sales Guidance; Maintaining $48 FVE
No-moat Walgreens Boots Alliance reported solid 2023 first-quarter results with sales and EPS mainly in line with our expectations on an adjusted basis. After slight adjustments to our full-year outlook, our assumptions remain in line with guidance, and we are maintaining our $48 fair value estimate. Shares appear undervalued.